Clinical Trial Update: Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study [Phase 1]

View source ↗

Summary

Phase 1 study reporting bioavailability and ADME data for [14C]-labeled SK-1404, including an IV microtracer assessment; the nocturia trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• SK-1404 (SK-1404)

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Nocturia | Phase 1 | Status: COMPLETED